EPA Ends Federal Union Contracts, Following Department of Veterans Affairs
EPA terminates federal union contracts, following a similar action by the Department of Veterans Affairs earlier this week.
Monthly Archives
August 2025
Ruben Gallego’s Iowa State Fair Visit Sparks 2028 Speculations
Sen. Ruben Gallego faces criticism for supporting US Cabinet nominations, sparking speculation about a potential…
Rising Suicide Rates in Rural America Linked to Lack of Mental Health Care
Rural areas in America face a rising suicide crisis, primarily due to lack of access to mental health care – an…
‘CT Officials Criticize Trump’s End to ‘Solar for All’ Program’
"Connecticut officials condemn Trump's decision to terminate the Solar for All program, restricting access to affordable solar energy."
US Departments Reviewing Short-Term, Limited-Duration Insurance Definition
US Departments reconsidering definition of short-term insurance; will not enforce actions against non-compliant…
Trump’s Executive Order Could Reshape US Science, Centralize Power Over…
Trump's executive order centralizes control over research grants, sparking fear of political influence over U.S…
Trump’s Consideration for Reviving Presidential Fitness Test
Stay updated on the ever-changing landscape of education in the U.S by subscribing to Chalkbeat’s free weekly newsletter.
Past Memories of the Presidential Fitness Test
For many Americans over 30, the Presidential Fitness Test brings back a wave of mixed emotions. Top performers take pride in their agility to make pull-ups look effortless, while…
Trump Nominates Pro-Tariff Economist Stephen Miran for Federal Reserve Board
Get to know Stephen Miran, the 41-year-old millennial nominated by Trump for the Fed's board of governors, and his…
Trump Administration Subsidizes…
Trump administration's 25% steel tariff and 2.5% tax credit for metallurgical coal inadvertently subsidizes foreign…
Glofitamab Treatment for DLBCL Shows Cost Savings Over Epcoritamab in US Healthcare
An economic model reveals glofitamab offers DLBCL patient cost savings versus epcoritamab, despite higher adverse event and treatment administration costs.